Stay updated with breaking news from Ar T. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Clinical-stage Arcellx raised $123.8 million from its IPO, which the company will use to advance to a pivotal test for its lead program, a CAR T-cell therapy for multiple myeloma. Though Arcellx trails its large pharmaceutical rivals, the biotech contends its technology produces cell therapies with key advantages.
Cell culture is one of the most widely used techniques in cellular and molecular biology. The process involves the cultivation of cells outside a living organism under controlled conditions, which enables researchers to study the physiology and biochemistry of cells.
Two patients with chronic lymphocytic leukemia who were among the first to receive the groundbreaking therapy were still in remission a decade later.
In 2010, doctors treated Doug Olson’s leukemia with an experimental gene therapy that...
However, labeling notes a potential increase in neurologic toxicity.